Summary & Overview
CPT 0415T: Repositioning Atrial or Ventricular Transvenous Electrode for CCM
CPT code 0415T covers repositioning of an atrial or ventricular transvenous electrode for a cardiac contractility modulation (CCM) system, a specialized device procedure used in select patients with heart failure. Nationally, this code captures a discrete device-related intervention that affects device function, perioperative workflow, and claims processing for electrophysiology services. Key payers in the review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
This publication provides a concise overview of clinical context and billing considerations for 0415T, including typical sites of service (hospital-based electrophysiology labs and catheterization suites) and the procedural focus on lead repositioning for CCM systems. Readers will find benchmarks for payer coverage and payment patterns where available, summaries of common modifiers used in device and procedure billing, and clinical context explaining when lead repositioning is performed. Data not available in the input will be noted as such. The content is intended to support coding, billing, and administrative teams, as well as clinicians who coordinate device-related procedures, with clear, national-level information on the use and reporting of CPT code 0415T.
Billing Code Overview
CPT code 0415T describes the repositioning of an atrial or ventricular transvenous electrode for a cardiac contractility modulation (CCM) system. The procedure involves adjusting an electrode that transmits and receives electrical impulses; electrodes are typically attached to insulated wire leads that are placed transvenously into the heart.
Service type: Device-related electrophysiology procedure involving lead manipulation and repositioning.
Typical site of service: Hospital inpatient or outpatient cardiac electrophysiology lab or cardiac catheterization suite.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with symptomatic heart failure with reduced ejection fraction who previously received a cardiac contractility modulation (CCM) implant presents with recurrent chest discomfort and evidence of atrial or ventricular lead malfunction on device interrogation. The patient is evaluated in the electrophysiology clinic and scheduled for a same-day or short-stay procedure in the cardiac catheterization lab or electrophysiology suite. Under conscious sedation or general anesthesia, the electrophysiologist accesses the existing transvenous lead system, confirms lead instability or malposition by fluoroscopy and device testing, and repositions the atrial or ventricular transvenous electrode to restore appropriate sensing and delivery of CCM therapy. Intra-procedural testing verifies acceptable lead parameters and absence of complications. Post-procedure, the patient is monitored for vascular access issues, arrhythmia, or infection and discharged home or admitted for observation depending on clinical stability and institutional protocols. Typical site of service is an outpatient hospital-based electrophysiology lab or ambulatory surgery center; service type is an interventional cardiac electrophysiology procedure involving lead revision of a CCM system.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for lead repositioning due to complexity (document details and rationale). |
23 | Unusual anesthesia | Use when procedural anesthesia is medically necessary and not normally required for this procedure (document reason). |
26 | Professional component | Use when reporting only the physician’s professional interpretation or service separate from technical facility component. |
51 | Multiple procedures | Use when multiple distinct procedures are performed in the same session and payer requires reporting of multiple-procedure modifier. |
52 | Reduced services | Use when the procedure is partially reduced or not completed as originally planned (document extent). |
53 | Discontinued procedure | Use when procedure is started but terminated due to extenuating circumstances (document reason). |
62 | Two surgeons | Use when two surgeons with different expertise are required to perform the procedure concurrently. |
66 | Surgical team | Use when a surgical team is necessary and members provide distinct portions of the procedure. |
78 | Return to OR for related procedure during global period | Use when the patient returns to the operating room for a related procedure during the global period. |
80 | Assistant surgeon | Use when an assistant surgeon is documented and payer requires reporting the assistant. |
81 | Minimum assistant surgeon | Use when a minimal assistant surgeon role is documented. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207RH0000X | Cardiac Electrophysiology | Electrophysiologists perform CCM lead revisions and device programming. |
| 207RC0000X | Cardiology | Interventional cardiologists with device expertise may perform or assist with lead repositioning. |
| 208D00000X | General Surgery | Cardiothoracic surgeons may be involved when surgical exposure is required or complications occur. |
| 163WL0500X | Nurse Practitioner | Advanced practice clinicians in electrophysiology clinics involved in pre- and post-procedural care. |
| 207LH0000X | Internal Medicine | Hospitalist or cardiology inpatient teams manage medical optimization and post-procedure care. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
I50.2 | Systolic (congestive) heart failure | Heart failure with reduced ejection fraction is the primary indication for CCM therapy and for lead revision when device therapy is compromised. |
I50.9 | Heart failure, unspecified | Used when heart failure is documented but specific type is not specified; relevant when CCM system requires lead repositioning due to failure to deliver therapy. |
I42.0 | Dilated cardiomyopathy | Common underlying structural cause of reduced ejection fraction and indication for CCM device therapy; lead issues may arise with remodeling. |
I48.0 | Paroxysmal atrial fibrillation | Atrial arrhythmias can affect CCM sensing or therapy delivery and may necessitate atrial lead repositioning. |
T82.89XA | Other mechanical complication of other cardiac device, implant and graft, initial encounter | Captures lead malfunction, displacement, or other mechanical complications requiring repositioning of CCM electrodes. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
33208 | Insertion or replacement of permanent pacemaker lead, transvenous, ventricular | May be performed if lead repositioning is unsuccessful and a new ventricular lead is required during the same episode of care. |
33207 | Insertion or replacement of permanent pacemaker lead, transvenous, atrial | May be performed when atrial lead revision cannot be achieved by repositioning and replacement is necessary. |
33233 | Removal of pacemaker lead(s), transvenous extraction by traction and/or simple manual technique | May precede or accompany lead repositioning if extraction of a malfunctioning lead is required. |
33249 | Insertion of temporary transvenous pacing electrode, without permanent pacemaker | May be used temporarily intra-procedurally if hemodynamic support or pacing is required during lead manipulation. |
93660 | Comprehensive electrophysiologic evaluation including insertion and repositioning of electrode catheters | May be performed during the same session for diagnostic mapping or to assess arrhythmia substrate while addressing lead position. |